John Martin is a partner with Capitol Counsel. Having worked in both the public and private sectors, he brings extensive knowledge to the firm’s health practice team. His wealth of knowledge in healthcare policy and government affairs has been honed through his previous roles as Vice President of Government Affairs at Pardes Biosciences and CRISPR Therapeutics, as well as his service as Principal Associate Commissioner for Legislation at the FDA under Commissioner Scott Gottlieb.
While at FDA oversaw passage of the 2017 & 2018 User Fee Agreements, House passage of Over-the-Counter Monograph reform, the SUPPORT Act, and the advancement of the VALID Act.
During his time in Arkansas, he developed and secured legislative approval for Arkansas Works, the Governor’s conservative reforms to Medicaid expansion.
In the private sector, Martin secured new DRG codes for innovative cancer treatments and worked with NIH, BARDA, and the Biden Administration to advance a new oral anti-viral treatment for COVID-19.